The natural history of clinically complete responders to neoadjuvant chemotherapy for urothelial carcinoma of the bladder

Journal of Urology

Volumn 192, Issue 3, 2014, Pages 696-701

  Meyer, Alexa ^a   Ghandour, Rashed ^a   Bergman, Ari ^a   Castaneda, Crystal ^a   Wosnitzer, Matthew ^a   Hruby, Greg ^a   Benson, Mitchell ^a   McKiernan, James ^a  

^a Department of Medicine   (United States)

Author keywords

carcinoma; cystectomy; drug therapy; neoplasm invasiveness; urinary bladder

Indexed keywords

CARBOPLATIN; CISPLATIN; GEMCITABINE;

ADJUVANT THERAPY; AGED; ARTICLE; BLADDER BIOPSY; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CYSTECTOMY; CYSTOSCOPY; CYTOLOGY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUSCLE INVASIVE BLADDER CANCER; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; ADULT; BLADDER CARCINOMA; CANCER SURGERY; MEDICAL RECORD REVIEW; TREATMENT REFUSAL;

CARCINOMA; CYSTECTOMY; DRUG THERAPY; NEOPLASM INVASIVENESS; URINARY BLADDER;

AGED; CARCINOMA, TRANSITIONAL CELL; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MALE; NEOADJUVANT THERAPY; REMISSION INDUCTION; RETROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS;

EID: 84906077018     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2014.03.078     Document Type: Article

References (17)

1. National Cancer Institute, Surveillance, Epidemiology, and End Results Program: SEER Stat Fact Sheets: Bladder Cancer. Available at http://seer.cancer.gov/statfacts/html/urinb.html. Accessed May 23, 2013.
2. S. Jones Non-muscle-invasive bladder cancer (Ta, T1, and CIS) 10th ed. A.J. Wein, L.R. Kavoussi, A.C. Novick, Campbell-Walsh Urology vol 3 2012 Saunders Philadelphia 2335
3. Centers for Disease Control and Prevention: Top Ten Cancers Among Men. Available at http://www.cdc.gov/Features/dsMenTop10Cancers/. Accessed May 23, 2013.
4. H.B. Grossman, R.B. Natale, and C.M. Tangen et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer N Engl J Med 349 2003 859
5. M.E. Nielsen, G.S. Palapattu, and P.I. Karakiewicz et al. A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome BJU Int 100 2007 1015
6. C.N. Sternberg, V. Pansadoro, and F. Calabro et al. Can patient selection for bladder preservation be based on response to chemotherapy? Cancer 97 2003 1644
7. R.W. deVere White, P.N. Lara Jr., and B. Goldman et al. A sequential treatment approach to myoinvasive urothelial cancer: a phase II Southwest Oncology Group trial (S0219) J Urol 181 2009 2476
8. H.W. Herr Outcome of patients who refuse cystectomy after receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer Eur Urol 54 2008 126
9. G. Griffiths, R. Hall, and R. Sylvester et al. International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial J Clin Oncol 29 2011 2171
10. F. Petrelli, A. Coinu, and M. Cabiddu et al. Correlation of pathologic complete response with survival after neoadjuvant chemotherapy in bladder cancer treated with cystectomy: a meta-analysis Eur Urol 65 2014 350
11. C.N. Sternberg, J. Bellmunt, and G. Sonpavde et al. ICUD-EAU International Consultation on Bladder Cancer 2012: chemotherapy for urothelial carcinoma-neoadjuvant and adjuvant settings Eur Urol 63 2013 58
12. R. Rosenblatt, A. Sherif, and E. Rintala et al. Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer Eur Urol 61 2012 1229
13. G. Niegisch, A. Lorch, and M.J. Droller et al. Neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: which patients benefit? Eur Urol 64 2013 355
14. J. Lokich, and N. Anderson Carboplatin versus cisplatin in solid tumors: an analysis of the literature Ann Oncol 9 1998 13
15. H.W. Herr, D.F. Bajorin, and H.I. Scher Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome J Clin Oncol 16 1998 1298
16. M. Housset, C. Maulard, and Y. Chretien et al. Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study J Clin Oncol 11 1993 2150
17. M.S. Wosnitzer, J. Domingo-Domenech, and M. Castillo-Martin et al. Predictive value of microtubule associated proteins tau and stathmin in patients with nonmuscle invasive bladder cancer receiving adjuvant intravesical taxane therapy J Urol 186 2011 2094